These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 16450386)

  • 1. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells.
    Alva JA; Zovein AC; Monvoisin A; Murphy T; Salazar A; Harvey NL; Carmeliet P; Iruela-Arispe ML
    Dev Dyn; 2006 Mar; 235(3):759-67. PubMed ID: 16450386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium.
    Monvoisin A; Alva JA; Hofmann JJ; Zovein AC; Lane TF; Iruela-Arispe ML
    Dev Dyn; 2006 Dec; 235(12):3413-22. PubMed ID: 17072878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract.
    Shao X; Somlo S; Igarashi P
    J Am Soc Nephrol; 2002 Jul; 13(7):1837-46. PubMed ID: 12089379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain.
    Sinnayah P; Lindley TE; Staber PD; Davidson BL; Cassell MD; Davisson RL
    Physiol Genomics; 2004 Jun; 18(1):25-32. PubMed ID: 15069166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization.
    Kogata N; Arai Y; Pearson JT; Hashimoto K; Hidaka K; Koyama T; Somekawa S; Nakaoka Y; Ogawa M; Adams RH; Okada M; Mochizuki N
    Circ Res; 2006 Apr; 98(7):897-904. PubMed ID: 16543497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice.
    Gustafsson E; Brakebusch C; Hietanen K; Fässler R
    J Cell Sci; 2001 Feb; 114(Pt 4):671-6. PubMed ID: 11171372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Odontoblast-specific expression of cre recombinase successfully deletes gene segments flanked by loxP sites in mouse teeth.
    Sreenath TL; Cho A; Thyagarajan T; Kulkarni AB
    Genesis; 2003 Feb; 35(2):94-9. PubMed ID: 12533791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination.
    Safran M; Kim WY; Kung AL; Horner JW; DePinho RA; Kaelin WG
    Mol Imaging; 2003 Oct; 2(4):297-302. PubMed ID: 14717328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination.
    Betz UA; Vosshenrich CA; Rajewsky K; Müller W
    Curr Biol; 1996 Oct; 6(10):1307-16. PubMed ID: 8939573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a smooth muscle-targeted cre recombinase mouse reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation.
    Regan CP; Manabe I; Owens GK
    Circ Res; 2000 Sep; 87(5):363-9. PubMed ID: 10969033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse opsin promoter-directed Cre recombinase expression in transgenic mice.
    Le YZ; Zheng L; Zheng W; Ash JD; Agbaga MP; Zhu M; Anderson RE
    Mol Vis; 2006 Apr; 12():389-98. PubMed ID: 16636658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
    Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
    Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission.
    Sakai K; Miyazaki Ji
    Biochem Biophys Res Commun; 1997 Aug; 237(2):318-24. PubMed ID: 9268708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse.
    Schnütgen F; Doerflinger N; Calléja C; Wendling O; Chambon P; Ghyselinck NB
    Nat Biotechnol; 2003 May; 21(5):562-5. PubMed ID: 12665802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.